{"id":"https://openalex.org/W2181608237","doi":null,"title":"Single nucleotide polymorphism (SNPS) analysis of Mu-opioid receptors (OPRM1) using denaturing high performance liquid chromatography (DHPLC) among the intravenous drug users","display_name":"Single nucleotide polymorphism (SNPS) analysis of Mu-opioid receptors (OPRM1) using denaturing high performance liquid chromatography (DHPLC) among the intravenous drug users","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2181608237","mag":"2181608237"},"language":"en","primary_location":{"id":"pmh:oai:psasir.upm.edu.my:35386","doi":null,"is_oa":true,"landing_page_url":"http://psasir.upm.edu.my/id/eprint/35386/1/Single%20nucleotide%20polymorphism%20%28SNPS%29%20analysis%20of%20Mu-opioid%20receptors%20%28OPRM1%29%20using%20denaturing%20high%20performance%20liquid%20chromatography%20%28DHPLC%29%20among%20the%20intravenous%20drug%20users.pdf","pdf_url":"http://psasir.upm.edu.my/id/eprint/35386/1/Single%20nucleotide%20polymorphism%20%28SNPS%29%20analysis%20of%20Mu-opioid%20receptors%20%28OPRM1%29%20using%20denaturing%20high%20performance%20liquid%20chromatography%20%28DHPLC%29%20among%20the%20intravenous%20drug%20users.pdf","source":{"id":"https://openalex.org/S4377196260","display_name":"Universiti Putra Malaysia Institutional Repository (Universiti Putra Malaysia)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I130343225","host_organization_name":"Universiti Putra Malaysia","host_organization_lineage":["https://openalex.org/I130343225"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://psasir.upm.edu.my/id/eprint/35386/1/Single%20nucleotide%20polymorphism%20%28SNPS%29%20analysis%20of%20Mu-opioid%20receptors%20%28OPRM1%29%20using%20denaturing%20high%20performance%20liquid%20chromatography%20%28DHPLC%29%20among%20the%20intravenous%20drug%20users.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056594335","display_name":"Lay Kek Teh","orcid":"https://orcid.org/0000-0002-2830-4263","observed_orcids":["https://orcid.org/0000-0002-2830-4263"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lay Kek Teh","raw_affiliation_strings":["Faculty of Pharmacy"],"raw_orcid":"https://orcid.org/0000-0002-2830-4263","affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087376959","display_name":"Zakaria Bannur","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130343225","display_name":"Universiti Putra Malaysia","ror":"https://ror.org/02e91jd64","country_code":"MY","type":"education","lineage":["https://openalex.org/I130343225"]},{"id":"https://openalex.org/I4210138650","display_name":"Universiti Teknologi MARA System","ror":"https://ror.org/030847t23","country_code":"MY","type":"education","lineage":["https://openalex.org/I4210138650","https://openalex.org/I82724352"]},{"id":"https://openalex.org/I82724352","display_name":"Universiti Teknologi MARA","ror":"https://ror.org/05n8tts92","country_code":"MY","type":"education","lineage":["https://openalex.org/I82724352"]}],"countries":["MY"],"is_corresponding":false,"raw_author_name":"Zakaria Bannur","raw_affiliation_strings":["Universiti Putra Malaysia","Universiti Teknologi MARA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universiti Putra Malaysia","institution_ids":["https://openalex.org/I130343225"]},{"raw_affiliation_string":"Universiti Teknologi MARA","institution_ids":["https://openalex.org/I4210138650","https://openalex.org/I82724352"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028332715","display_name":"Zainul Amiruddin Zakaria","orcid":"https://orcid.org/0000-0001-5525-7821","observed_orcids":["https://orcid.org/0000-0001-5525-7821"]},"institutions":[{"id":"https://openalex.org/I130343225","display_name":"Universiti Putra Malaysia","ror":"https://ror.org/02e91jd64","country_code":"MY","type":"education","lineage":["https://openalex.org/I130343225"]},{"id":"https://openalex.org/I4210138650","display_name":"Universiti Teknologi MARA System","ror":"https://ror.org/030847t23","country_code":"MY","type":"education","lineage":["https://openalex.org/I4210138650","https://openalex.org/I82724352"]},{"id":"https://openalex.org/I82724352","display_name":"Universiti Teknologi MARA","ror":"https://ror.org/05n8tts92","country_code":"MY","type":"education","lineage":["https://openalex.org/I82724352"]}],"countries":["MY"],"is_corresponding":false,"raw_author_name":"Zainul Amiruddin Zakaria","raw_affiliation_strings":["Universiti Putra Malaysia","Universiti Teknologi MARA"],"raw_orcid":"https://orcid.org/0000-0001-5525-7821","affiliations":[{"raw_affiliation_string":"Universiti Putra Malaysia","institution_ids":["https://openalex.org/I130343225"]},{"raw_affiliation_string":"Universiti Teknologi MARA","institution_ids":["https://openalex.org/I4210138650","https://openalex.org/I82724352"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034749324","display_name":"Fazleen Haslinda Mohd Hatta","orcid":"https://orcid.org/0000-0002-0331-1037","observed_orcids":["https://orcid.org/0000-0002-0331-1037"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fazleen Haslinda Mohd Hatta","raw_affiliation_strings":["Faculty of Pharmacy"],"raw_orcid":"https://orcid.org/0000-0002-0331-1037","affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101416082","display_name":"Mohd Zaki Salleh","orcid":"https://orcid.org/0000-0001-9882-0661","observed_orcids":["https://orcid.org/0000-0001-9882-0661"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mohd Zaki Salleh","raw_affiliation_strings":["Faculty of Pharmacy"],"raw_orcid":"https://orcid.org/0000-0001-9882-0661","affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1223,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.40727028,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"6","issue":null,"first_page":"281","last_page":"287"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.73580002784729,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.73580002784729,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10261","display_name":"Genetic Associations and Epidemiology","score":0.17870000004768372,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.029999999329447746,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oprm1","display_name":"OPRM1","score":0.8870000243186951},{"id":"https://openalex.org/keywords/mu-opioid-receptor","display_name":"mu-opioid receptor","score":0.9860000014305115},{"id":"https://openalex.org/keywords/single-nucleotide-polymorphisms","display_name":"single nucleotide polymorphisms","score":0.9800000190734863},{"id":"https://openalex.org/keywords/people-who-inject-drugs","display_name":"people who inject drugs","score":0.9929999709129333},{"id":"https://openalex.org/keywords/opioid-addiction-risk","display_name":"opioid addiction risk","score":0.6470000147819519},{"id":"https://openalex.org/keywords/genetic-polymorphism","display_name":"genetic polymorphism","score":0.718999981880188},{"id":"https://openalex.org/keywords/tridimensional-personality-questionnaire","display_name":"Tridimensional Personality Questionnaire","score":0.8420000076293945},{"id":"https://openalex.org/keywords/novelty-seeking","display_name":"novelty seeking","score":0.9449999928474426},{"id":"https://openalex.org/keywords/harm-avoidance","display_name":"harm avoidance","score":0.9980000257492065},{"id":"https://openalex.org/keywords/g-protein-coupled-receptors","display_name":"G protein-coupled receptors","score":0.6269999742507935},{"id":"https://openalex.org/keywords/drug-addiction","display_name":"drug addiction","score":0.3610000014305115}],"concepts":[{"id":"https://openalex.org/C2776582870","wikidata":"https://www.wikidata.org/wiki/Q5659011","display_name":"Harm avoidance","level":4,"score":0.7618929743766785},{"id":"https://openalex.org/C2776053618","wikidata":"https://www.wikidata.org/wiki/Q3022285","display_name":"Denaturing high performance liquid chromatography","level":4,"score":0.7608321905136108},{"id":"https://openalex.org/C153209595","wikidata":"https://www.wikidata.org/wiki/Q501128","display_name":"Single-nucleotide polymorphism","level":4,"score":0.6673915982246399},{"id":"https://openalex.org/C31467283","wikidata":"https://www.wikidata.org/wiki/Q912147","display_name":"Genotyping","level":4,"score":0.6066524982452393},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.5684836506843567},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4275428354740143},{"id":"https://openalex.org/C187288502","wikidata":"https://www.wikidata.org/wiki/Q641118","display_name":"Personality","level":2,"score":0.34983789920806885},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.30443352460861206},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.29405084252357483},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2761356830596924},{"id":"https://openalex.org/C49105822","wikidata":"https://www.wikidata.org/wiki/Q176996","display_name":"Polymerase chain reaction","level":3,"score":0.25169870257377625},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.22837692499160767},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.2195969521999359},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.19271746277809143},{"id":"https://openalex.org/C2865642","wikidata":"https://www.wikidata.org/wiki/Q378132","display_name":"Big Five personality traits","level":3,"score":0.10574623942375183},{"id":"https://openalex.org/C77805123","wikidata":"https://www.wikidata.org/wiki/Q161272","display_name":"Social psychology","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:psasir.upm.edu.my:35386","doi":null,"is_oa":true,"landing_page_url":"http://psasir.upm.edu.my/id/eprint/35386/1/Single%20nucleotide%20polymorphism%20%28SNPS%29%20analysis%20of%20Mu-opioid%20receptors%20%28OPRM1%29%20using%20denaturing%20high%20performance%20liquid%20chromatography%20%28DHPLC%29%20among%20the%20intravenous%20drug%20users.pdf","pdf_url":"http://psasir.upm.edu.my/id/eprint/35386/1/Single%20nucleotide%20polymorphism%20%28SNPS%29%20analysis%20of%20Mu-opioid%20receptors%20%28OPRM1%29%20using%20denaturing%20high%20performance%20liquid%20chromatography%20%28DHPLC%29%20among%20the%20intravenous%20drug%20users.pdf","source":{"id":"https://openalex.org/S4377196260","display_name":"Universiti Putra Malaysia Institutional Repository (Universiti Putra Malaysia)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I130343225","host_organization_name":"Universiti Putra Malaysia","host_organization_lineage":["https://openalex.org/I130343225"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"mag:2181608237","doi":null,"is_oa":true,"landing_page_url":"http://psasir.upm.edu.my/id/eprint/35386/","pdf_url":null,"source":{"id":"https://openalex.org/S2764469077","display_name":"International Journal of Pharmacy and Pharmaceutical Sciences","issn_l":"0975-1491","issn":["0975-1491","2656-0097"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4322697801","host_organization_name":"Innovare Academic Sciences","host_organization_lineage":["https://openalex.org/P4322697801"],"host_organization_lineage_names":["Innovare Academic Sciences"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Pharmacy and Pharmaceutical Sciences","raw_type":null}],"best_oa_location":{"id":"pmh:oai:psasir.upm.edu.my:35386","doi":null,"is_oa":true,"landing_page_url":"http://psasir.upm.edu.my/id/eprint/35386/1/Single%20nucleotide%20polymorphism%20%28SNPS%29%20analysis%20of%20Mu-opioid%20receptors%20%28OPRM1%29%20using%20denaturing%20high%20performance%20liquid%20chromatography%20%28DHPLC%29%20among%20the%20intravenous%20drug%20users.pdf","pdf_url":"http://psasir.upm.edu.my/id/eprint/35386/1/Single%20nucleotide%20polymorphism%20%28SNPS%29%20analysis%20of%20Mu-opioid%20receptors%20%28OPRM1%29%20using%20denaturing%20high%20performance%20liquid%20chromatography%20%28DHPLC%29%20among%20the%20intravenous%20drug%20users.pdf","source":{"id":"https://openalex.org/S4377196260","display_name":"Universiti Putra Malaysia Institutional Repository (Universiti Putra Malaysia)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I130343225","host_organization_name":"Universiti Putra Malaysia","host_organization_lineage":["https://openalex.org/I130343225"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9907000064849854}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2181608237.pdf"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W1976459616","https://openalex.org/W2000246453","https://openalex.org/W2008179229","https://openalex.org/W2011895147","https://openalex.org/W2012743573","https://openalex.org/W2017514322","https://openalex.org/W2079708017","https://openalex.org/W2080253238","https://openalex.org/W2087556312","https://openalex.org/W2095097888","https://openalex.org/W2102675531","https://openalex.org/W2106158413","https://openalex.org/W2110634897","https://openalex.org/W2111504943","https://openalex.org/W2115551883","https://openalex.org/W2136145948","https://openalex.org/W2161777075","https://openalex.org/W2167800126"],"related_works":["https://openalex.org/W2017514322","https://openalex.org/W7100978439","https://openalex.org/W2013796305","https://openalex.org/W3011684113","https://openalex.org/W2228294786","https://openalex.org/W2954063160","https://openalex.org/W2394131626","https://openalex.org/W2724937626","https://openalex.org/W2883055060","https://openalex.org/W4408058696"],"abstract_inverted_index":{"Objectives:":[0],"The":[1],"genetic":[2],"polymorphisms":[3],"of":[4,20,45,83,111,136,144,155,168,173,176,180,189],"OPRM1":[5,25,46],"among":[6,102,158],"the":[7,18,42,75,103,142,145,152,159,166],"intravenous":[8],"drug":[9,59],"users":[10],"(IVDUs)":[11],"and":[12,17,50,61,92,105,120,128,149,170,178],"healthy":[13,52,106],"controls":[14],"were":[15,55,80,85,96],"investigated":[16],"risk":[19],"addiction":[21,190],"in":[22,41,47],"relation":[23],"to":[24,38,57,98],"was":[26,36,64],"predicted.":[27],"Methods:":[28],"PCR-denaturing":[29],"high":[30],"performance":[31],"liquid":[32],"chromatography":[33],"(DHPLC)":[34],"method":[35],"developed":[37],"investigate":[39],"SNPs":[40,79],"coding":[43],"regions":[44],"93":[48],"IVDUs":[49,104],"100":[51],"controls.":[53,107],"Subjects":[54],"confirmed":[56],"be":[58],"addicts":[60],"their":[62],"personality":[63],"studied":[65],"using":[66,182],"validated":[67],"Tridimensional":[68],"Personality":[69],"Questionnaires":[70],"(TPQ).":[71],"Results:":[72],"Based":[73],"on":[74],"results":[76],"obtained,":[77],"seven":[78],"detected;":[81],"two":[82],"them":[84],"previously":[86],"associated":[87],"with":[88,124],"addiction.":[89],"Homozygous":[90],"OPRM1:c.118GG":[91],"heterozygous":[93],"OPRM1:c.118AG":[94],"variants":[95,172],"found":[97],"have":[99],"higher":[100,115],"frequencies":[101],"In":[108,162],"addition,":[109],"carriers":[110],"OPRM1:c.118G":[112],"allele":[113],"scored":[114],"for":[116,187],"novelty":[117],"seeking":[118],"(NS)":[119],"harm":[121],"avoidance":[122],"(HA)":[123],"more":[125],"explorative,":[126],"neurotic":[127],"uninhibited":[129],"personalities.":[130],"We":[131],"identified":[132],"a":[133],"new":[134,169],"variant":[135],"OPRM1:c.77C>G":[137],"which":[138],"is":[139],"located":[140],"at":[141],"N-terminus":[143],"G-coupled":[146],"protein":[147],"receptor":[148],"possibly":[150],"decreases":[151],"binding":[153],"affinity":[154],"its":[156],"ligands":[157],"IVDUs.":[160],"Conclusion:":[161],"conclusion,":[163],"DHPLC":[164],"allows":[165],"detection":[167],"existing":[171],"OPRM1.":[174],"Genotyping":[175],"OPRM1:c.118A>G":[177],"assessment":[179],"personalities":[181],"TPQ":[183],"provide":[184],"valuable":[185],"tools":[186],"determination":[188],"risk.":[191]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2016-06-24T00:00:00"}
